Nalbuphine
An opioid analgesic used in pain management
| Nalbuphine | |
|---|---|
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Nalbuphine is a synthetic opioid used primarily in the management of moderate to severe pain. It is known for its mixed agonist-antagonist properties, which make it unique among opioid analgesics.
Pharmacology
Nalbuphine acts as an agonist at the kappa-opioid receptor and as a partial antagonist at the mu-opioid receptor. This dual action results in effective analgesia with a lower risk of respiratory depression compared to pure mu-opioid agonists like morphine.
Mechanism of Action
Nalbuphine binds to opioid receptors in the central nervous system, altering the perception of and response to pain. Its kappa agonist activity is responsible for its analgesic effects, while its mu antagonist activity helps mitigate some of the adverse effects commonly associated with opioids, such as respiratory depression and euphoria.
Clinical Use
Nalbuphine is used in various clinical settings, including postoperative pain management, labor pain, and as an adjunct to anesthesia. It is administered via intravenous, intramuscular, or subcutaneous injection.
Advantages
One of the main advantages of nalbuphine is its ceiling effect on respiratory depression, which makes it safer in terms of overdose risk compared to other opioids. This property is particularly beneficial in settings where monitoring of respiratory function is limited.
Side Effects
Common side effects of nalbuphine include sedation, dizziness, nausea, and sweating. Due to its partial antagonist properties, it may precipitate withdrawal symptoms in patients who are physically dependent on other opioids.
Regulation and Availability
Nalbuphine is not classified as a controlled substance in many countries, which facilitates its use in various medical settings. However, its availability may vary depending on local regulations and healthcare policies.
Related pages
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian